Rome, Italy 11th November, 2022 – Cartilago, a clinical stage regenerative medicine company founded by Cube Labs, announced today the results from an analysis of
ROME, Italy Cartilago, a clinical stage regenerative medicine company, has announced a clinical study for Regen Longevity, a regenerative peptide candidate being developed to increase
Cartilago has received seed investment from CDP Venture Capital – National Innovation Fund of Italy’s “Italy Venture II – Southern Italy Business Fund.” The fund